Atlas Trials

A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor Fluctuations

Clinical trial NCT02782481 · WITHDRAWN

Trial details

NCT number
NCT02782481
Sponsor
NeuroDerm Ltd.
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2016-08-01
Primary completion
2018-10-15
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.